Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
HN1 (gene)
Introduction
Hematological and neurological expressed 1 protein is a protein that in humans is encoded by the HN1 gene.[1][2]
NOTE: HN1 can also refer to the Notch 1 gene.
References
References
- ↑ Zhou G, Wang J, Zhang Y, Zhong C, Ni J, Wang L, Guo J, Zhang K, Yu L, Zhao S (Apr 2004). “Cloning, expression and subcellular localization of HN1 and HN1L genes, as well as characterization of their orthologs, defining an evolutionarily conserved gene family”. Gene. 331: 115–23. doi:10.1016/j.gene.2004.02.025. PMID 15094197.
- ↑ “Entrez Gene: HN1 hematological and neurological expressed 1”.
Further reading
Further reading
- Laughlin KM, Luo D, Liu C, Shaw G, Warrington KH Jr, Law BK, Harrison JK (2009). “Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest”. Differentiation. 78 (1): 35–44. doi:10.1016/j.diff.2009.04.001. PMC 2867035. PMID 19427096.
- Laughlin KM, Luo D, Liu C, Shaw G, Warrington KH Jr, Qiu J, Yachnis AT, Harrison JK (2009). “Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas”. Pathol Oncol Res. 15 (3): 437–44. doi:10.1007/s12253-008-9147-4. PMC 2819207. PMID 19145478.
- Zujovic V, Luo D, Baker HV, Lopez MC, Miller KR, Streit WJ, Harrison JK (2005). “The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene”. J Neurosci Res. 82 (5): 581–91. doi:10.1002/jnr.20676. PMID 16267826.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
- Zougman A, WiÅ›niewski JR (2006). “Beyond linker histones and high mobility group proteins: global profiling of perchloric acid soluble proteins”. J. Proteome Res. 5 (4): 925–34. doi:10.1021/pr050415p. PMID 16602700.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Li D, Gonzalez O, Bachinski LL, Roberts R (2001). “Human protein tyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in families with ARVD”. Gene. 256 (1–2): 237–43. doi:10.1016/S0378-1119(00)00347-4. PMID 11054553.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.